C[C@]12CCC(O)CC1CCC1C2CC[C@]2(C)C(c3cc(C(F)(F)F)[nH]n3)CCC12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?